Dubai South and MOHAP aim to boost pharma manufacturing
Dubai South has signed a Memorandum of Understanding (MoU) with the UAE Ministry of Health and Prevention (MOHAP) as part of its efforts to strengthen cooperation with the pharmaceutical sector.
The MOU is part of a shared commitment between the two entities aimed at achieving government integration in line with the UAE Vision 2021.
It aims to provide a single framework for developing the procedures for issuing license and registration for pharmaceutical manufacturers in Dubai South.
The agreement seeks to promote the implementation of legislation for the pharmaceutical and medical equipment industry.
The MoU was signed by Dr. Amin Hussein Al Amiri, assistant undersecretary for Public Health Policy and Licensing office, chairman of Supreme Pharmacovigilance Committee at MOHAP and Mohsen Ahmad, CEO of Logistics District at Dubai South.
Ahmad emphasised that the new agreement is an important move towards improving the performance of the pharmaceutical sector.
The agreement too would help promote its contribution in supporting the UAE’s efforts to diversify the economy and shift to the post-oil era.
Dubai South's efforts are similar to those made by JAFZA recently to boost local pharma manufacturing. At Arab Health earlier this year, Sultan Bin Sulayem, chairman and CEO of DP World, highlighted Jebel Ali Freezone's credentials as a pharma hub in the region.
“The healthcare and pharmaceutical are key strategic targets in the Dubai Industrial Strategy 2030. As a trade and logistics hub, JAFZA fully supports this vision and we are determined to help it grow,” said Bin Sulayem.
“The freezone is already the regional headquarters for many international healthcare companies and as part of our efforts we are engaging with pharmaceutical and medical equipment companies to encourage them to transfer manufacturing facilities, knowledge and research centres to JAFZA and other DP World industrial park facilities, which offer world class services and support systems,” he added.